Unichem Laboratories Stock Prediction 2026: Analyst Targets, Forecast and Key Levels
- June 23, 2026
- Posted by: Kunal Singla
- Category: News
NSE: UNICHEMLAB | CMP Rs 448.2. 52W High Rs 657.95. 52W Low Rs 278.2. Analyst consensus Rs 521.0. Bull Rs 573.7.
The Unichem Laboratories stock prediction for 2026 points to an analyst consensus target of Rs 521.0, with a bull case of Rs 573.7 and a bear case of Rs 412.3 based on current fundamentals and sector outlook. Unichem Laboratories is trading at Rs 448.2 on the NSE, and market participants are watching it closely against the Nifty 50 and Sensex.
This article covers the Unichem Laboratories stock prediction in detail, with brokerage target levels, time horizon analysis, key business drivers, risk factors and the views of Ankit Jaiswal and Kunal Singla on the current risk-reward.
Click Here – Get Free Investment Predictions
Unichem Laboratories Company Overview and Key Data
Unichem Laboratories (NSE: UNICHEMLAB) is a pharma-sector company listed on the National Stock Exchange. It operates in a competitive space and is tracked by investors monitoring the Nifty Pharma for sector-level cues. The table below summarises key stock metrics for the Unichem Laboratories stock prediction.
| Parameter | Details |
|---|---|
| NSE Symbol | UNICHEMLAB |
| Company | Unichem Laboratories |
| Sector | Pharma |
| CMP (Rs) | 448.2 |
| 52-Week High (Rs) | 657.95 |
| 52-Week Low (Rs) | 278.2 |
| Analyst Consensus Target (Rs) | 521.0 |
| Bull Case (Rs) | 573.7 |
| Bear Case (Rs) | 412.3 |
What Analysts Say About the Unichem Laboratories Stock Prediction 2026
The Unichem Laboratories stock prediction is shaped by estimates from multiple analysts tracking the stock. Based on publicly available research, the analyst consensus target for Unichem Laboratories stands at Rs 521.0, reflecting a range of views from optimistic to conservative. The table below summarises key analyst estimates.
| Analyst / Research | Rating | 12M Target (Rs) |
|---|---|---|
| ICICI Securities | Buy | 567.3 |
| Systematix | Add | 512.0 |
| Emkay Global | Neutral | 483.6 |
| Consensus | — | 521.0 |
Each Unichem Laboratories share price target in this table is derived from publicly available analyst estimates and may be revised as quarterly results and macro data evolve. No two analysts share the exact same Unichem Laboratories stock prediction, which reflects genuine uncertainty about FY27 demand and sector dynamics. These are analyst estimates, not a guaranteed return from Univest.
Unichem Laboratories Stock Prediction by Time Horizon
Short-Term Unichem Laboratories Stock Prediction: 3 to 6 Months
In the short term, the Unichem Laboratories stock prediction is guided by near-term earnings delivery and broader market sentiment. Ankit Jaiswal notes that Rs 475.1 is a realistic near-term target if earnings momentum holds. The stock needs to hold above its 52-week low of Rs 278.2 to maintain a constructive near-term view.
12-Month Unichem Laboratories Stock Prediction for 2026
The 12-month Unichem Laboratories stock prediction stands at a consensus of Rs 521.0, representing potential upside from the current market price. The highest estimate of Rs 567.3 and the most conservative at Rs 483.6 show the spread of analyst views. Analysts revisit this Unichem Laboratories stock forecast after every quarterly earnings release.
Long-Term Unichem Laboratories Stock Prediction: FY27 to FY28
Kunal Singla observes that if the company executes on its strategic roadmap over the next two years, the long-term share price target points toward Rs 627.5 by FY28, assuming compounding earnings growth and a potential sector multiple re-rating. This is a long-horizon Unichem Laboratories stock forecast, not a near-term prediction.
Key Factors Driving the Unichem Laboratories Stock Prediction 2026
US Generic Pipeline and ANDA Approvals
A robust pipeline of abbreviated new drug applications creates medium-term revenue. Each new FDA approval adds high-margin, recurring generic revenue streams. Ankit Jaiswal watches this factor closely when forming the 2026 share price view.
Domestic Formulations Growth
Rising health insurance penetration and chronic disease burden expand the branded generics market. Domestic volume growth provides earnings stability. Kunal Singla watches this factor closely when forming the 2026 share price view.
API Backward Integration
In-house API supply reduces raw material cost volatility and shields the company from Chinese supply chain disruptions, improving gross margins. Ankit Jaiswal watches this factor closely when forming the 2026 share price view.
Emerging Markets Expansion
Penetrating underpenetrated markets in Africa, Latin America and Southeast Asia diversifies revenue and reduces dependence on the competitive US generics segment. Kunal Singla watches this factor closely when forming the 2026 share price view.
Bull Case and Bear Case for Unichem Laboratories Stock Prediction 2026
| Scenario | Target (Rs) | Key Condition |
|---|---|---|
| Bull Case | 573.7 | Strong earnings beat, sector tailwinds, FII inflows |
| Base Case | 515.4 | In-line earnings, stable macro, ~15% upside |
| Bear Case | 412.3 | Earnings miss, sector headwinds, risk-off markets |
These Unichem Laboratories stock prediction scenarios are illustrative and based on broad analyst estimates. They are not a guaranteed return forecast from Univest.
Reading the Unichem Laboratories Stock Prediction: Analyst Perspectives
Ankit Jaiswal notes that the Unichem Laboratories stock prediction from ICICI Securities at Rs 567.3 reflects confidence in the company’s ability to sustain earnings momentum and expand margins in FY27. The Buy rating from ICICI Securities is based on the expectation that current headwinds are temporary and the business fundamentals remain intact.
Kunal Singla observes that the more cautious Neutral stance from Emkay Global at Rs 483.6 flags valuation concern at current levels, with the analyst preferring to wait for evidence of demand revival before turning constructive. The gap between the optimistic and conservative Unichem Laboratories stock forecast reflects genuine uncertainty about FY27 demand and margin trajectory.
Both analysts agree that the consensus target of Rs 521.0 represents a reasonable base case for investors with a 12-month horizon, provided quarterly results stay in line with expectations. Ankit Jaiswal and Kunal Singla both recommend tracking the Unichem Laboratories stock prediction against actual quarterly delivery rather than reacting to short-term price moves. These are analyst estimates and are subject to revision.
Key Risks to the Unichem Laboratories Stock Prediction 2026
US FDA Observations and Import Alerts
Any USFDA warning letter or import alert at a manufacturing facility can immediately block US shipments and severely impact near-term revenue. Investors should factor this risk into the 2026 outlook.
US Generics Pricing Pressure
Structural price erosion in US generics due to buyer consolidation and competition compresses per-unit realisations year on year. Investors should factor this risk into the 2026 outlook.
DPCO Price Controls
Government-mandated drug price controls under DPCO limit domestic price increases and squeeze branded formulation margins. Investors should factor this risk into the 2026 outlook.
Raw Material Cost Volatility
Dependence on Chinese APIs creates supply chain vulnerability. Any cost spike in key ingredients directly pressures gross margins. Investors should factor this risk into the 2026 outlook.
How to Monitor the Unichem Laboratories Stock Prediction
To stay updated on the Unichem Laboratories stock prediction and track real-time price movements, investors can use verified data platforms.
Check the Univest Screener for live data and updated targets.
Key data points to monitor include quarterly earnings, promoter shareholding changes, FII and DII flow data, and movement in the Nifty 50 which sets the broad market tone for share prices broadly.
Conclusion
The Unichem Laboratories stock prediction for 2026 presents a consensus target of Rs 521.0, a bull case of Rs 573.7 and a bear case of Rs 412.3. Brokerage views range from ICICI Securities’s optimistic Buy at Rs 567.3 to Emkay Global’s cautious Neutral at Rs 483.6.
Investors should review quarterly earnings, study the bull and bear scenario table, and consult a SEBI-registered advisor before making investment decisions based on any stock prediction.
Download the Univest iOS App or Univest Android App to track Unichem Laboratories share price live and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Unichem Laboratories Stock Prediction 2026
What is the Unichem Laboratories stock prediction for 2026?
Ans. The Unichem Laboratories stock prediction 2026 consensus stands at Rs 521.0. Bull case Rs 573.7, bear case Rs 412.3.
What do analysts say about the Unichem Laboratories stock prediction?
Ans. ICICI Securities has a Buy rating with a 12-month Unichem Laboratories stock forecast of Rs 567.3, Systematix has an Add at Rs 512.0, and Emkay Global is Neutral at Rs 483.6. These are analyst estimates, not guaranteed returns.
What is the Unichem Laboratories share price target for FY27 to FY28?
Ans. The long-term Unichem Laboratories stock prediction points toward Rs 627.5 by FY28, contingent on sustained earnings growth and sector re-rating. This is a forecast, not a guaranteed outcome.
What is the Unichem Laboratories 52-week high and low?
Ans. The Unichem Laboratories 52-week high is Rs 657.95 and the 52-week low is Rs 278.2. These levels are key reference points when evaluating the Unichem Laboratories stock prediction.
What are the key risks to the Unichem Laboratories stock prediction?
Ans. Key risks to the Unichem Laboratories stock prediction include sector headwinds, FII selling pressure, earnings misses, global macro uncertainty and regulatory changes. Always evaluate risks before acting on any stock forecast.
Is Unichem Laboratories a good buy in 2026?
Ans. Whether Unichem Laboratories is a good buy depends on your investment horizon and risk tolerance. The Unichem Laboratories stock prediction consensus of Rs 521.0 implies potential upside. Consult a SEBI-registered advisor before investing.
How do I track the Unichem Laboratories stock prediction?
Ans. You can track the Unichem Laboratories stock prediction on the Univest Screener, which provides real-time price data, analyst targets and fundamental metrics. Verify all data with the official NSE website before acting on any stock forecast.
